BALTIMORE – Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today it has hired Jose Gallo as senior director of biometrics consulting. In this position, Gallo will lead C-TASC’s consulting team as it works with pharmaceutical and biotechnology companies to address all biometric issues associated with clinical trial submissions. This will include standard CRO activities plus provide support for Phase IV trial work, post-submission work and communication of trial results. Additionally, Gallo will support C-TASC’s current work with government agencies, including the National Institutes of Health (NIH) and the Food and Drug Administration (FDA).
Gallo has more than 23 years of experience in healthcare technology with over 17 of those years spent in managerial roles. Before joining C-TASC, Gallo worked as an independent statistical consultant and provided advice on issues relating to the FDA and the European Medicines Agency (EMA) submissions. Previously, he was the director of biometrics at Therakos, a division of Johnson & Johnson, where he developed and led a biometrics department that supported clinical research associated with the efficacy and safety of Extracorporeal Photopheresis in various therapeutic areas. Prior to that, he was the senior director of statistics and data management at GPC-Biotech, Inc. Gallo holds a Ph.D. and master’s degree in statistics from the University of Florida.
For 20 years, C-TASC has specialized in supporting best practices management of clinical trials and studies for government, university and private organizations. The company has grown rapidly in the last three years, nearly doubling its revenue and number of employees since 2007. In that time, it has added professional consultation in all areas of clinical trial management to its offered services, incorporated a proprietary Web-based software system for clinical trials management and developed a relationship with the Food and Drug Administration to convert legacy data into the new standard Study Data Tabulation Model (SDTM) format.
“C-TASC employs a very talented and experienced team of biostatisticians, and in recent years we’ve made a concerted effort to grow the statistical consulting side of our business to allow more companies to benefit from their knowledge and abilities,” said Dr. Bruce Thompson, president of C-TASC. “With his extensive background and biometric expertise, Jose is the ideal person to lead our consulting team as we continue to expand our service offerings for the pharmaceutical and biotechnology industries.”
“Having worked in the pharmaceutical/biotechnology industry for more than 20 years, I know quite well what these companies need in a contract research organization (CRO), and C-TASC best encompasses the hands-on experience and commitment to integrity and quality they require,” said Gallo. “I plan to greatly increase C-TASC’s involvement with these companies by continuing to grow the statistical consulting department and enhancing its services.
About C-TASC
Based near Baltimore, Clinical Trials & Surveys Corp. (C-TASC) is a clinical trials solutions company that has supported best practices management of clinical trials and studies for government, university and private organizations since 1989. C-TASC has a successful research history in cancer, cardiovascular disease, AIDS, pulmonary disease, Cystic Fibrosis, sleep disorders and pharmaco-epidemiology. C-TASC’s software group utilizes the firm’s StudyCTMSTM product suite to provide investigators with complete Web-based trial management designed to deliver FDA-acceptable data. The C-TASC professional services group provides expert consultation in all areas of clinical trial management including medical and statistical study design, project management, data conversion including FDA SDTM formatting, performance monitoring, data quality control and analysis as well as support for study publication and presentation. For more information about C-TASC’s projects, products and services, please visit www.c-tasc.com.